TWS 119,
TWS-119,
TWS119,
TWS119,
601514-19-6,
TWS-119,
TWS 119,
3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol,
GSK inhibitor XII,
GSK-3beta Inhibitor XII, TWS119,
3-(6-(3-aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenol,
CHEMBL405759,
Neurogenesis Inducer, TWS119,
3-((6-(3-AMINOPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)OXY)PHENOL,
3-{[6-(3-aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy}phenol,
Phenol, 3-[[6-(3-aminophenyl)-1H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]-,
K00245,
MLS006011018,
GTPL5980,
SCHEMBL5559045,
GSK-3BETA INHIBITOR XII,
CHEBI:91384,
CTK8F1085,
AOB4460,
DTXSID00429550,
EX-A151,
TWS119/,
VPVLEBIVXZSOMQ-UHFFFAOYSA-N,
BCPP000029,
HMS3229M16,
HMS3655M07,
BCP02458,
ABP000906,
BDBM50325986,
HSCI1_000361,
IN1312,
MFCD09037535,
s1590,
ZINC11757505,
GSK-3 Inhibitor XII, TWS119,
GSK-3|A Inhibitor XII, TWS119,
AKOS016368735,
AKOS028109054,
Phenol, 3-[[6-(3-aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]-,
ACN-052766,
CCG-206847,
CS-0224,
LS41101,
PB22215,
QC-8224,
RL04269,
NCGC00346638-01,
NCGC00346638-07,
4CA-1292,
AK172138,
BC638790,
HY-10590,
SMR004702816,
TWS119, >=98% (HPLC),
AB0007969,
RT-013129,
ST1191244,
FT-0700339,
SW219785-1,
X7612,
EC-000.2371,
KS-00000058,
A11223,
Q-4470,
J-511451,
BRD-K94176593-001-01-1,
TWS 119, 601514-19-6,
3-(6-(3-aminophenyl)-7H-pyrrolo[2,3-dpyrimidin-4-yloxy)phenol,
3-[6-(3-amino-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-phenol,
3-[[6-(3-aminophenyl)-1H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]-phenol,
3-[6-(3-Amino-phenyl)-7H-pyrrolo[2,3,-d]pyrimidin-4-yloxy]-phenol,
D0T8KR,
cc-510,
C18H14N4O2,
CID9549289,
NSC 405020,
B1540,
C547688,
3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxyphenol ditrifluoroacetate,